Get startedLog in
    Picture of Wakamoto Pharmaceutical Co logo

    4512 — Wakamoto Pharmaceutical Co Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Wakamoto Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-911-703285212159
    Depreciation
    Non-Cash Items-58.5-30.8-22314.4-478
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital349413-193-39.8-200
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Taxes Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-155163339632-107
    Capital Expenditures-177-451-303-163-556
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1.76252353180553
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-179-20050.617.1-2.35
    Financing Cash Flow Items-0.001-0.001-0.001-0.001-0.001
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-44.4-3.83-1.62-1.61-105
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-378-39.9388647-215